Lupin's NRC approved a grant of 65,251 employee stock options under its 2025 scheme on June 30, 2026.
Each option has an exercise price of ₹2.00 and entitles the holder to one equity share upon vesting.
The options vest over three years in equal annual instalments starting July 2027, subject to performance conditions.
The exercise period for vested options extends up to eight years from the July 1, 2026 grant date.